A team from the University of Chicago Medicine Comprehensive Cancer Center has received a five-year, $3.9-million award from the National Cancer Institute to serve as a Lead Academic Participating Site for the newly created National Clinical Trials Network (NCTN). The University of Chicago team r...
Somatic mutations in cancer genomes are caused by multiple mutational processes, each of which generates a characteristic mutational signature1. Here, as part of the Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium2 of the International Cancer Genome Consortium (ICGC) and The Cancer Genome At...
Department of Surgery, Division of Surgical Oncology, Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA Evangeline S. Mose, Randall P. French & Andrew M. Lowy Department of Medicine, Division of Hematology/Oncology, Moores Cancer Center, University of California, San...
of Medicine and Adjunct Professor of Drug Discovery, First Hospital of Wenzhou Medical University. Previously, he was Director, Computational Biology and Biomedical Informatics at the University of Pennsylvania Cancer Center 2000-2003. He served as Global Head of Computational Genomics at Roche ...
C. Camargo Cancer Center, Sao Paulo, Brazil (Curado); Department of Environmental Health, College of Public Health, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia (Dahlawi); Department of Dermatology, Case Western Reserve University, Cleveland, Ohio (Damiani); Pediatric Department, ...
CHICAGO, July 21 (Xinhua) -- More than one-third of young adult cancer survivors found it difficult to go back to normal life two years after initial diagnosis, a study of the University of Michigan (UM) in cooperation with Radboud University Medical Center in the Netherlands finds. ...
lung cancer, but also the overall health and life expectancy of the individual," said Kevin ten Haaf of Erasmus MC, University Medical Center in Rotterdam, Netherlands. "Doing so will further help to identify those for whom screening is most beneficial and reduce the potential harms of ...
“This is the least aggressive, wimpiest form of prostate cancer that is literally incapable of causing symptoms or spreading to other parts of the body,” said University of Chicago Medicine’s Dr. Scott Eggener, who is reviving a debate about how to explain the threat to worried patients....
We kindly acknowledge the assistance of the Research Resource Cores at the University of Illinois-Chicago; Dr. Klara Valyi-Nagy at the UI Biorepository for oversight of tissue collection for the primary prostate cells, Dr. Balaji Ganesh at the Flow Cytometry Center, Zhengdeng Lei at the Center...
Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, 60611, USA Jie Xu, Hongbo Yang, Tingting Liu & Feng Yue Department of Biochemistry and Molecular Biology, College of Medicine, The Pennsylvania State University, Hershey, PA, 17033, USA Jie Xu, James R Broach...